

소개
Recent advances in robot?assisted urologic surgery have significantly improved the quality of life for patients with prostate, bladder, and kidney cancers by enabling less-invasive procedures, reducing blood loss, and preserving functional outcomes. These developments may also influence diagnostic value; however, their overall impact remains insufficiently evaluated due to limited data and short follow?up periods.



